生検デバイスの世界市場2016-2026

◆英語タイトル:Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026
◆商品コード:FMI703071
◆発行会社(調査会社):Future Market Insights
◆発行日:2017年1月10日
◆ページ数:277
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,110,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、生検デバイスの世界市場について調査・分析し、生検デバイスの世界市場動向、生検デバイスの世界市場規模、市場予測、セグメント別生検デバイス市場分析、地域別市場規模(北米市場、南米市場、アジア市場、日本市場、ヨーロッパ市場など)、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Government initiatives in cancer treatment to fuel growth of the global biopsy device market during the projected period
Global demand for biopsy devices is increasing, supported by rising incidence of cancer. Future Market Insights presents in-depth analysis of the global biopsy device market for the forecast period, 2016–2026. Revenue from the global biopsy device market is expected to register a CAGR of 6.5% during the assessment period and is expected to be valued at nearly US$ 2,700 Mn by 2026 end.

Increasing incidence of cancer and favourable reimbursement programs are factors expected to drive revenue growth of the global biopsy device market during the assessment period

The guidance system segment was estimated to account for 16.1% revenue share of the global biopsy device market by 2016 end and is expected to gain 222 BPS in market share by 2026 over 2016, owing to an increase in the awareness of early detection of breast cancer.

The needles segment was estimated to account for 37.6% revenue share of the global biopsy device market by 2016 end and is expected to lose 125 BPS in market share by 2026 over 2016. The segment is expected to reach nearly US$ 960 Mn by 2026 owing to an increasing awareness among people regarding the early detection of cancer.

Global Biopsy Device Market Absolute $ Opportunity by Product Type, 2016–2026

Guidance system segment is estimated to create absolute $ opportunity of more than US$ 15 Mn in 2017 over 2016. Revenue from guidance system segment is anticipated to register a CAGR of 7.9% over 2016–2026, to reach more than US$ 480 Mn towards the close of the forecast period

Biopsy needles segment is estimated to create absolute $ opportunity of nearly US$ 30 Mn in 2017 over 2016. Revenue from biopsy needles segment is anticipated to register a CAGR of 6.2% over 2016–2026, to reach nearly US$ 960 Mn by 2026 end

Guns segment is estimated to create absolute $ opportunity of nearly US$ 25 Mn in 2017 over 2016. Revenue from guns segment is anticipated to witness a CAGR of 6.8% over 2016–2026, to reach more than US$ 700 Mn towards the close of 2026

Reagents and kits segment is estimated to create absolute $ opportunity of more than US$ 3 Mn in 2017 over 2016. Revenue from reagents and kits segment is anticipated to witness a CAGR of 6.4% over 2016–2026, to reach nearly US$ 120 Mn at the end of the assessment period

Others (Brushes, Curettes and Punches etc.) segment is estimated to create absolute $ opportunity of nearly US$ 10 Mn in 2017 over 2016. Revenue from Others segment is anticipated to witness a CAGR of 5.3% over 2016–2026, to reach more than US$ 360 Mn by 2026 end

Global Biopsy Device Market Attractiveness Analysis by Product Type, 2016–2026

Needles segment dominated the global biopsy device market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period. Needles segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period. The segment accounted for 37.7% value share in 2016 and is projected to account for 36.5% share by 2026 end. Guns segment is expected to be the second most lucrative segment in the global biopsy device market, with a market attractiveness index of 1.3 during the forecast period. The increasing requirement for more advanced and innovative technology products in the field of biopsy and growing usage of biopsy needles makes it the most attractive segment in the global biopsy device market. Companies operating in the global biopsy device market are actively engaged in mergers, acquisitions and partnerships to capture a larger share of the market in the near future

The global biopsy device market is a fragmented market with about 69% market share contributed by CR Bard, Becton, Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc., Cook Medical, Devicor Medical Products Inc. and Argon Medical Inc. Companies are entering into strategic mergers and acquisitions to improve their biopsy device product portfolio and are focussing on distributional agreements to overcome issues related to product availability in various geographical areas.

Analyst Viewpoint

“In the coming decade, liquid biopsy procedure is likely to pose a major threat to the biopsy device market”

Liquid biopsy offers non-invasive diagnostic tests for detecting cancer as it provides a simple, relatively less expensive blood, urine or plasma test to detect malignancy in any part of the patient’s body. Liquid biopsy is expected to provide a better sample for any type of diagnosis and analysis as it can be taken repeatedly. This overcomes the challenge associated with repeated tissue samples. Liquid samples help detect disease progression in real time, predict outcomes and switch treatment when required and potentially increase the life expectancy of the patient. Thus, liquid biopsy procedure is likely to be a major threat to the global biopsy device market in the coming decade.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3. Global Biopsy Device Analysis Scenario

3.1. Pricing Analysis

3.1.1. Pricing Assumptions

3.1.2. Price Projections Per Region

3.2. Market Size (US$ Mn) and Forecast

3.2.1. Market Size and Y-o-Y Growth

3.2.2. Absolute $ Opportunity

3.3. Market Overview

3.3.1. Value Chain

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6. Global Incidence of Cancer

4.7. Global Trends

5. Global Biopsy Device Analysis and Forecasts, By Product

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type

5.3. Y-o-Y Growth Projections By Product Type

5.4. Market Value and Volume Forecast By Product, 2016–2026

5.4.1. Guidance System

5.4.1.1. Stereotactic X-Ray Guided Biopsy

5.4.1.2. Ultrasound Guided Biopsy

5.4.1.3. MRI Guided Biopsy

5.4.2. Needles

5.4.2.1. Core Needle

5.4.2.2. Fine Aspiration Needles

5.4.3. Guns

5.4.4. Reagents and Kits

5.4.5. Others (Brushes, Curettes and Punches etc.)

5.5. Market Attractiveness By Product

6. Global Biopsy Device Analysis and Forecasts, By Application

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Application

6.3. Y-o-Y Growth Projections By Application

6.4. Market Value Forecast By Application, 2016–2026

6.4.1. Scientific Research

6.4.2. Medical Diagnostics

6.5. Market Attractiveness By Application

7. Global Biopsy Device Analysis and Forecasts, By End Users

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By End Users

7.3. Y-o-Y Growth Projections By End Users

7.4. Market Value Forecast By End Users, 2016–2026

7.4.1. Hospitals

7.4.2. Specialized Oncology Centers

7.4.3. Diagnostic Centers

7.4.4. Research Institutes

7.5. Market Attractiveness By End Users

8. Global Biopsy Device Analysis and Forecasts, By Region

8.1. Basis Point Share (BPS) Analysis By Region

8.2. Y-o-Y Growth Projections By Region

8.3. Market Value Forecast By Region

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. APEJ

8.3.6. Japan

8.3.7. MEA

8.4. Market Attractiveness By Region

9. North America Biopsy Device Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.1.3. Key Regulations

9.2. Market Value and Volume Forecast By Product, 2016–2026

9.2.1. Guidance System

9.2.1.1. Stereotactic X-Ray Guided Biopsy

9.2.1.2. Ultrasound Guided Biopsy

9.2.1.3. MRI Guided Biopsy

9.2.2. Needles

9.2.2.1. Core Needle

9.2.2.2. Fine Aspiration Needles

9.2.3. Guns

9.2.4. Reagents and Kits

9.2.5. Others (Brushes, Curettes and Punches etc.)

9.3. Market Value Forecast By Application, 2016–2026

9.3.1. Scientific Research

9.3.2. Medical Diagnostics

9.4. Market Value Forecast By End Users, 2016–2026

9.4.1. Hospitals

9.4.2. Specialized Oncology Centers

9.4.3. Diagnostic Centers

9.4.4. Research Institutes

9.5. Market Value Forecast By Country, 2016–2026

9.5.1. US

9.5.2. Canada

9.6. Market Attractiveness Analysis

9.6.1. By Product

9.6.2. By Application

9.6.3. By End Users

9.6.4. By Country

10. Latin America Biopsy Device Analysis and Forecast

10.1.Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.1.3. Key Regulations

10.2.Market Value and Volume Forecast By Product, 2016–2026

10.2.1. Guidance System

10.2.1.1. Stereotactic X-Ray Guided Biopsy

10.2.1.2. Ultrasound Guided Biopsy

10.2.1.3. MRI Guided Biopsy

10.2.2. Needles

10.2.2.1. Core Needle

10.2.2.2. Fine Aspiration Needles

10.2.3. Guns

10.2.4. Reagents and Kits

10.2.5. Others (Brushes, Curettes and Punches etc.)

10.3.Market Value Forecast By Application, 2016–2026

10.3.1. Scientific Research

10.3.2. Medical Diagnostics

10.4.Market Value Forecast By End Users, 2016–2026

10.4.1. Hospitals

10.4.2. Specialized Oncology Centers

10.4.3. Diagnostic Centers

10.4.4. Research Institutes

10.5.Market Value Forecast By Country, 2016–2026

10.5.1. Argentina

10.5.2. Brazil

10.5.3. Mexico

10.5.4. Rest of Latin America

10.6.Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Application

10.6.3. By End Users

10.6.4. By Country

11. Western Europe Biopsy Device Analysis and Forecast

11.1.Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.1.3. Key Regulations

11.2.Market Value and Volume Forecast By Product, 2016–2026

11.2.1. Guidance System

11.2.1.1. Stereotactic X-Ray Guided Biopsy

11.2.1.2. Ultrasound Guided Biopsy

11.2.1.3. MRI Guided Biopsy

11.2.2. Needles

11.2.2.1. Core Needle

11.2.2.2. Fine Aspiration Needles

11.2.3. Guns

11.2.4. Reagents and Kits

11.2.5. Others (Brushes, Curettes and Punches etc.)

11.3.Market Value Forecast By Application, 2016–2026

11.3.1. Scientific Research

11.3.2. Medical Diagnostics

11.4.Market Value Forecast By End Users, 2016–2026

11.4.1. Hospitals

11.4.2. Specialized Oncology Centers

11.4.3. Diagnostic Centers

11.4.4. Research Institutes

11.5.Market Value Forecast By Country, 2016–2026

11.5.1. UK

11.5.2. France

11.5.3. Germany

11.5.4. Italy

11.5.5. Spain

11.5.6. Nordic

11.5.7. Benelux

11.5.8. Rest of Western Europe

11.6.Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Application

11.6.3. By End Users

11.6.4. By Country

12. Eastern Europe Biopsy Device Analysis and Forecast

12.1.Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.1.3. Key Regulations

12.2.Market Value and Volume Forecast By Product, 2016–2026

12.2.1. Guidance System

12.2.1.1. Stereotactic X-Ray Guided Biopsy

12.2.1.2. Ultrasound Guided Biopsy

12.2.1.3. MRI Guided Biopsy

12.2.2. Needles

12.2.2.1. Core Needle

12.2.2.2. Fine Aspiration Needles

12.2.3. Guns

12.2.4. Reagents and Kits

12.2.5. Others (Brushes, Curettes and Punches etc.)

12.3.Market Value Forecast By Application, 2016–2026

12.3.1. Scientific Research

12.3.2. Medical Diagnostics

12.4.Market Value Forecast By End Users, 2016–2026

12.4.1. Hospitals

12.4.2. Specialized Oncology Centers

12.4.3. Diagnostic Centers

12.4.4. Research Institutes

12.5.Market Value Forecast By Country, 2016–2026

12.5.1. Russia

12.5.2. Poland

12.5.3. Rest of Eastern Europe

12.6.Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Application

12.6.3. By End Users

12.6.4. By Country

13. APEJ Biopsy Device Analysis and Forecast

13.1.Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country

13.1.2. Y-o-Y Growth Projections By Country

13.1.3. Key Regulations

13.2.Market Value and Volume Forecast By Product, 2016–2026

13.2.1. Guidance System

13.2.1.1. Stereotactic X-Ray Guided Biopsy

13.2.1.2. Ultrasound Guided Biopsy

13.2.1.3. MRI Guided Biopsy

13.2.2. Needles

13.2.2.1. Core Needle

13.2.2.2. Fine Aspiration Needles

13.2.3. Guns

13.2.4. Reagents and Kits

13.2.5. Others (Brushes, Curettes and Punches etc.)

13.3.Market Value Forecast By Application, 2016–2026

13.3.1. Scientific Research

13.3.2. Medical Diagnostics

13.4.Market Value Forecast By End Users, 2016–2026

13.4.1. Hospitals

13.4.2. Specialized Oncology Centers

13.4.3. Diagnostic Centers

13.4.4. Research Institutes

13.5.Market Value Forecast By Country, 2016–2026

13.5.1. China

13.5.2. India

13.5.3. Australia & New Zealand

13.5.4. ASEAN

13.5.5. Rest of APEJ

13.6.Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Application

13.6.3. By End Users

13.6.4. By Country

14. Japan Biopsy Device Analysis and Forecast

14.1.Introduction

14.1.1. Basis Point Share (BPS) Analysis By Country

14.1.2. Y-o-Y Growth Projections By Country

14.1.3. Key Regulations

14.2.Market Value and Volume Forecast By Product, 2016–2026

14.2.1. Guidance System

14.2.1.1. Stereotactic X-Ray Guided Biopsy

14.2.1.2. Ultrasound Guided Biopsy

14.2.1.3. MRI Guided Biopsy

14.2.2. Needles

14.2.2.1. Core Needle

14.2.2.2. Fine Aspiration Needles

14.2.3. Guns

14.2.4. Reagents and Kits

14.2.5. Others (Brushes, Curettes and Punches etc.)

14.3.Market Value Forecast By Application, 2016–2026

14.3.1. Scientific Research

14.3.2. Medical Diagnostics

14.4.Market Value Forecast By End Users, 2016–2026

14.4.1. Hospitals

14.4.2. Specialized Oncology Centers

14.4.3. Diagnostic Centers

14.4.4. Research Institutes

14.5.Market Attractiveness Analysis

14.5.1. By Product

14.5.2. By Application

14.5.3. By End Users

15. MEA Biopsy Device Analysis and Forecast

15.1.Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.1.3. Key Regulations

15.2.Market Value and Volume Forecast By Product, 2016–2026

15.2.1. Guidance System

15.2.1.1. Stereotactic X-Ray Guided Biopsy

15.2.1.2. Ultrasound Guided Biopsy

15.2.1.3. MRI Guided Biopsy

15.2.2. Needles

15.2.2.1. Core Needle

15.2.2.2. Fine Aspiration Needles

15.2.3. Guns

15.2.4. Reagents and Kits

15.2.5. Others (Brushes, Curettes and Punches etc.)

15.3.Market Value Forecast By Application, 2016–2026

15.3.1. Scientific Research

15.3.2. Medical Diagnostics

15.4.Market Value Forecast By End Users, 2016–2026

15.4.1. Hospitals

15.4.2. Specialized Oncology Centers

15.4.3. Diagnostic Centers

15.4.4. Research Institutes

15.5.Market Value Forecast By Country, 2016–2026

15.5.1. GCC Countries

15.5.2. South Africa

15.5.3. North Africa

15.5.4. Rest of MEA

15.6.Market Attractiveness Analysis

15.6.1. By Product

15.6.2. By Application

15.6.3. By End Users

15.6.4. By Country

16. Competition Landscape

16.1. Competition Dashboard

16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

16.2.1. Becton, Dickinson and Company

16.2.2. Argon Medical Inc.

16.2.3. B. Braun Melsungen AG

16.2.4. Boston Scientific Inc.

16.2.5. C. R. Bard, Inc.

16.2.6. Hologic, Inc.

16.2.7. Cook Medical

16.2.8. INRAD Inc.

16.2.9. Devicor Medical Products Inc.

16.2.10. PLANMED OY



【レポートのキーワード】

生検デバイス

★調査レポート[生検デバイスの世界市場2016-2026] (コード:FMI703071)販売に関する免責事項を必ずご確認ください。
★調査レポート[生検デバイスの世界市場2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆